Research papers of the week – May 22, 2022

Micro-RNAs in Response to Active Forms of Vitamin D3 in Human Leukemia and Lymphoma Cells

Justyna Joanna Gleba, Dagmara Kłopotowska, Joanna Banach, Karolina Anna Mielko, Eliza Turlej, Magdalena Maciejewska, Andrzej Kutner, Joanna Wietrzyk
International Journal of Molecular Sciences

Ministerial score = 140.0
Journal Impact Factor (2020) = 5.924 (Q1)

international_journal_od_molecular_sciences.jpgNon-coding micro-RNA (miRNAs) regulate the protein expression responsible for cell growth and proliferation. miRNAs also play a role in a cancer cells’ response to drug treatment. Knowing that leukemia and lymphoma cells show different responses to active forms of vitamin D3, we decided to investigate the role of selected miRNA molecules and regulated proteins, analyzing if there is a correlation between the selected miRNAs and regulated proteins in response to two active forms of vitamin D3, calcitriol and tacalcitol. A total of nine human cell lines were analyzed: five leukemias: MV-4-1, Thp-1, HL-60, K562, and KG-1; and four lymphomas: Raji, Daudi, Jurkat, and U2932. We selected five miRNA molecules—miR-27b, miR-32, miR-125b, miR-181a, and miR-181b— and the proteins regulated by these molecules, namely, CYP24A1, Bak1, Bim, p21, p27, p53, and NF-kB. The results showed that the level of selected miRNAs correlates with the level of proteins, especially p27, Bak1, NFκB, and CYP24A1, and miR-27b and miR-125b could be responsible for the anticancer activity of active forms of vitamin D3 in human leukemia and lymphoma.

DOI:10.3390/ijms23095019

READ THE PAPER UPWr Base


magnacarta-logo.jpg eua-logo.png hr_logo.png logo.png eugreen_logo_simple.jpg iroica-logo.png bic_logo.png